School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI, 53703, USA.
Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Hanover, NH, 03755, USA.
Addict Sci Clin Pract. 2024 Apr 8;19(1):27. doi: 10.1186/s13722-024-00460-y.
Pharmacy-based screening and brief interventions (SBI) offer opportunities to identify opioid misuse and opioid safety risks and provide brief interventions that do not overly burden pharmacists. Currently, such interventions are being developed without patient input and in-depth contextual data and insufficient translation into practice. The purpose of this study is to qualitatively explore and compare patient and pharmacist perceptions and needs regarding a pharmacy-based opioid misuse SBI and to identify relevant SBI features and future implementation strategies.
Using the Consolidated Framework for Implementation Research, we conducted semi-structured interviews with 8 patients and 11 pharmacists, to explore needs and barriers to participating in a pharmacy-based SBI. We recruited a purposive sample of English-speaking patients prescribed opioids for chronic or acute pain and pharmacists practicing in varied pharmacies (small independent, large-chain, specialty retail) settings. We used an inductive content analysis approach to analyze patient interview data. Then through a template analysis approach involving comparison of pharmacist and patient themes, we developed strategies for SBI implementation.
Most patient participants were white, older, described living in suburban areas, and were long-term opioid users. We identified template themes related to individual, interpersonal, intervention, and implementation factors and inferred applications for SBI design or potential SBI implementation strategies. We found that patients needed education on opioid safety and general opioid use, regardless of opioid use behaviors. Pharmacists described needing patient-centered training, protocols, and scripts to provide SBI. A short-self-reported screening and brief interventions including counseling, naloxone, and involving prescribers were discussed by both groups.
Through this implementation-focused qualitative study, we identified patient needs such as opioid safety education delivered in a private and convenient format and pharmacist needs including training, workflow integration, protocols, and a time-efficient intervention for effective pharmacy-based SBI. Alternate formats of SBI using digital health technologies may be needed for effective implementation. Our findings can be used to develop patient-centered pharmacy-based SBI that can be implemented within actual pharmacy practice.
基于药房的筛查和简短干预(SBI)提供了识别阿片类药物滥用和阿片类药物安全风险的机会,并提供了不会给药剂师带来过重负担的简短干预措施。目前,这些干预措施正在制定中,没有患者的投入和深入的背景数据,也没有充分转化为实践。本研究的目的是定性探讨和比较患者和药剂师对基于药房的阿片类药物滥用 SBI 的看法和需求,并确定相关 SBI 特征和未来实施策略。
我们使用综合实施研究框架,对 8 名患者和 11 名药剂师进行了半结构化访谈,以探讨参与基于药房的 SBI 的需求和障碍。我们招募了一组有目的的英语患者,他们正在服用阿片类药物治疗慢性或急性疼痛,以及在不同药房(小型独立、大型连锁、专业零售)环境中工作的药剂师。我们使用了一种归纳内容分析方法来分析患者访谈数据。然后,通过模板分析方法比较药剂师和患者的主题,我们制定了 SBI 实施策略。
大多数患者参与者是白人,年龄较大,描述居住在郊区,是长期阿片类药物使用者。我们确定了与个人、人际、干预和实施因素有关的模板主题,并推断出 SBI 设计或潜在 SBI 实施策略的应用。我们发现,无论患者的阿片类药物使用行为如何,都需要进行阿片类药物安全和一般阿片类药物使用教育。药剂师描述了需要以患者为中心的培训、协议和脚本,以提供 SBI。简短的自我报告筛查和简短干预措施,包括咨询、纳洛酮和涉及处方医生,被两组讨论。
通过这项以实施为重点的定性研究,我们确定了患者的需求,例如以私密和方便的方式提供阿片类药物安全教育,以及药剂师的需求,包括培训、工作流程整合、协议和针对有效基于药房的 SBI 的高效干预措施。可能需要使用数字健康技术的替代 SBI 格式来实现有效的实施。我们的研究结果可以用于开发以患者为中心的基于药房的 SBI,该 SBI可以在实际药房实践中实施。